Meeting Banner
Abstract #0824

Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics

Haiyi Wang1, Lu Ma1, Zihua Su2, Ning Huang2, Xiao Xu3, Zhipeng Sun4, Aitao Guo5, and Huiyi Ye1

1Department of Radiology, Chinese PLA General Hospital, Beijing, People's Republic of China, 2Lift Science, Advanced Application Team, GE Healthcare China, Beijing, People's Republic of China, 3Lift Science, Advanced Application Team, GE Healthcare China, Shanghai, People's Republic of China, 4Department of Radiology, No.1 Hospital of Zhangjiakou, Zhangjiakou, People's Republic of China, 5Department of Pathology, Chinese PLA General Hospital, Beijing, People's Republic of China

Synopsis

In this prospective study on pharmacokinetic parameters (Ktrans & Ve) of renal tumors, we enrolled the patients with five common subtypes of renal tumor - clear cell renal cell carcinoma (ccRCC), papillary renal cell carcinoma (pRCC), chromophobic renal cell carcinoma (cRCC), uroepithelial carcinoma (UEC), and fat poor angiomyolipoma (fpAML) to undergo DCE-MRI pharmacokinetic studies. Our results demonstrated that ccRCC, pRCC, cRCC, UEC and fpAML are pharmacokinetically different (Ktrans & Ve). Ktrans could distinguish ccRCC from non-ccRCC (pRCC & cRCC) and differentiate fpAML with non-ccRCC with high specificity and sensitivity, which probably can facilitate the precise treatment of renal tumors in the future clinical practice.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords